6-134028417-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_145176.3(SLC2A12):c.1408G>A(p.Val470Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,613,458 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_145176.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC2A12 | NM_145176.3 | c.1408G>A | p.Val470Ile | missense_variant | 2/5 | ENST00000275230.6 | NP_660159.1 | |
SLC2A12 | XM_006715349.5 | c.1408G>A | p.Val470Ile | missense_variant | 2/3 | XP_006715412.1 | ||
SLC2A12 | XM_017010311.3 | c.1408G>A | p.Val470Ile | missense_variant | 2/3 | XP_016865800.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC2A12 | ENST00000275230.6 | c.1408G>A | p.Val470Ile | missense_variant | 2/5 | 1 | NM_145176.3 | ENSP00000275230.5 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250520Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135354
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461270Hom.: 0 Cov.: 31 AF XY: 0.0000371 AC XY: 27AN XY: 726888
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2024 | The c.1408G>A (p.V470I) alteration is located in exon 2 (coding exon 2) of the SLC2A12 gene. This alteration results from a G to A substitution at nucleotide position 1408, causing the valine (V) at amino acid position 470 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at